Medicon Valley biotech firms attract major UK investors to Copenhagen  

2006.05.30
Eight UK investment companies specialising in medical biotech are visiting Copenhagen 8th June to meet promising new Danish and Swedish biotech companies in Medicon Valley

Eight UK investment companies specialising in medical biotech are visiting Copenhagen 8th June to meet promising new Danish and Swedish biotech companies in Medicon Valley. The UK investors collectively administer approx. DKK 110 bn (USD 18.7 bn), and several of them are experts in Nordic biotech companies. The presentation programme, called Strictly Financing, has been organised by Medicon Valley Academy and UK Trade and Investment. HE David Frost, the new British Ambassador to Denmark will open the event.

Christian Hansen, partner of venture company Nordic Biotech says: "It is excellent that we can attract eight British venture companies to Copenhagen, and it shows that Medicon Valley in a European context is a very interesting biotech region." UK is Europe's leading biotech nation and according to Christian Hansen, its venture companies are highly qualified in biotech.

Investors attending the event include Merlin Bioscience, 3i, Advent Venture Partners, Atlas Venture and ETV Capital. Participating Medicon Valley companies include Action Pharma, Osteologix, ViroGates, Curalogic and DermaGen. The news was reported by Erhvervsbladet and on Medicon Valley Academy's website.

Link > Medicon Valley Academy 

Next step

Explore business cases

Please contact me

Name
Company
E-mail
Phone
How can we help you?

IDK
We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×